OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Pharmaceutics is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
High Molecular Weight Poly(glutamic acid) to Improve BMP2-Induced Osteogenic Differentiation	147
Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation	110
A Model Study to Assess Fibrillation and Product Stability to Support Peptide Drug Design	108
Understanding the Roles of Excipients in Moisture Management in Solid Dosage Forms	83
Correlating Differences in the Surface Activity to Interface-Induced Particle Formation in Different Protein Modalities: IgG mAb Versus Fc-Fusion Protein	75
Construction and Preclinical Evaluation of a ^124/125I-Labeled Specific Antibody Targeting PD-L2 in Lung Cancer	75
Coupled Discrete Phase and Eulerian Wall Film Models for Drug Deposition Efficacy Analysis in Human Respiratory Airways	71
NIR-II Navigation with an EGFR-Targeted Probe Improves Imaging Resolution and Sensitivity of Detecting Micrometastases in Esophageal Squamous Cell Carcinoma Xenograft Models	69
Analysis of Cimetidine Crystal Polymorphs by X-ray Absorption Near-Edge Spectroscopy	67
Fluorophore-Conjugated Anti-ICOS Antibody Enables Precise Prediction of Therapeutic Response of the STING Agonist in Colorectal Cancer via NIRF Imaging	67
Defining the Intravital Renal Disposition of Fluorescence-Quenched Exenatide	62
The Potency of Cowpea Mosaic Virus Particles for Cancer In Situ Vaccination Is Unaffected by the Specific Encapsidated Viral RNA	62
Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment	61
Issue Editorial Masthead	60
Mechanical Extrusion of the Plasma Membrane to Generate Ectosome-Mimetic Nanovesicles for Lung Targeting	59
Issue Publication Information	59
Issue Editorial Masthead	58
Exploration of Verticillins in High-Grade Serous Ovarian Cancer and Evaluation of Multiple Formulations in Preclinical In Vitro and In Vivo Models	57
⁶⁴Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer	56
Fluorescent Self-Reporting Lipid Nanoparticles for Nitric Oxide/Gene Co-Delivery and Combination Therapy	55
Co-amorphous Systems of Sinomenine with Platensimycin or Sulfasalazine: Physical Stability and Excipient-Adjusted Release Behavior	55
Deconstructing Annealing Phenomena in Modified Release Lipid Multiparticulates	54
Computational-Based Polyphenol Therapy for Nonsmall Cell Lung Cancer: Naringin Coamorphous Systems for Solubility and Bioavailability Enhancement	53
Immuno-PET Imaging of TNF-α in Colitis Using ⁸⁹Zr-DFO-infliximab	50
Correction to “Effects of PEGylation on Imaging Contrast of ⁶⁸Ga-Labeled Bicyclic Peptide PET Probes Targeting Nectin-4”	50

A Positron Emission Tomography Tracer Targeting the S2 Subunit of SARS-CoV-2 in Extrapulmonary Infections	50
Effect of Moisture Sorption and Lactose Type on Tablet Quality: A Hygroscopicity Study between Lactose Powder and Tablets	49
Quantitative Characterization of Clinically Relevant Drug-Metabolizing Enzymes and Transporters in Rat Liver and Intestinal Segments for Applications in PBPK Modeling	46
Pterostilbene-Loaded Soluplus/Poloxamer 188 Mixed Micelles for Protection against Acetaminophen-Induced Acute Liver Injury	46
Pharmacokinetics in Penguins Compared to Other Avian Species: A Review of Enrofloxacin and Voriconazole	45
In Vitro Release from Polymeric Core/Shell Nanoparticles through the Lens of Multiscale Modeling	44
Exploring Bimetallic Nanoparticles in Alzheimer’s Therapy: A Novel Bio-Assisted Synthesis with Multitarget Potential	43
Influence of Nucleation on Relaxation, Molecular Cooperativity, and Physical Stability of Celecoxib Glass	43
Structured Sponsorship: An Option for Improved Workplace Inclusion in the Pharmaceutical Sciences	42
Pharmacokinetic Bioequivalence between Generic and Originator Orally Inhaled Drug Products: Validity of Administration of Doses above the Approved Single Maximum Dose	42
Predicting Experimental B₂₂ Values and the Effects of Histidine Charge States for Monoclonal Antibodies Using Coarse-Grained Molecular Simulations	42
Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma	41
Investigating Key Molecular Descriptors Affecting Particle Size: A Predictive Exemplary Approach for Self-Emulsifying System	40
Stem Cell-Derived Extracellular Vesicles for Cancer Therapy and Tissue Engineering Applications	38
Bridging the Gap between Food Effects under Clinical Trial Conditions and Real Life: Modeling Delayed Gastric Emptying of Drug Substances and Gastric Content Volume Based on Meal Characteristics	38
Evaluation of a Tumor-Targeting Oligosaccharide Nanosystem in BNCT on an Orthotopic Hepatocellular Carcinoma Model	38